Report of an ISRTP Workshop: Progress and Barriers to Incorporating Alternative Toxicological Methods in the U.S
Overview
Toxicology
Authors
Affiliations
The workshop objectives were to explore progress in implementing new, revised and alternative toxicological test methods across regulatory evaluation frameworks and decision-making programs in the United States, to identify barriers and to develop recommendations to further promote adoption of approaches that reduce, refine, or replace the use of animal methods. The workshop included sessions on: (1) current research, development, and validation of alternative methods within the U.S. federal government; (2) emerging alternative methodologies with potential applications to a broad spectrum of toxicity evaluation strategies; (3) tiered evaluation ("intelligent testing") strategies; and (4) identification of, and recommendations to address, critical barriers that affect adoption and use of new, revised alternative toxicological test methods by U.S. regulatory agencies. Through facilitated discussion, a list of barriers and recommendations were developed and grouped into categories of economic/financial, scientific/technical, and regulatory/policy. Overall, participants from all sectors collectively supported catalyzing actions to promote more meaningful and rapid progress for research to develop alternative methods focused for use in regulatory programs, accelerated lab investigations to validate such alternative methods and adoption of regulatory frameworks which embrace and incorporate these validated alternatives.
Sanabria-de la Torre R, Fernandez-Gonzalez A, Quinones-Vico M, Montero-Vilchez T, Arias-Santiago S Biomedicines. 2020; 8(11).
PMID: 33142704 PMC: 7694072. DOI: 10.3390/biomedicines8110464.
Corneal pain and experimental model development.
McKay T, Seyed-Razavi Y, Ghezzi C, Dieckmann G, Nieland T, Cairns D Prog Retin Eye Res. 2018; 71:88-113.
PMID: 30453079 PMC: 6690397. DOI: 10.1016/j.preteyeres.2018.11.005.
Validation of in vitro assays in three-dimensional human dermal constructs.
Idrees A, Chiono V, Ciardelli G, Shah S, Viebahn R, Zhang X Int J Artif Organs. 2018; 41(11):779-788.
PMID: 29843544 PMC: 6210574. DOI: 10.1177/0391398818775519.
Gao S, Chen W, Zeng Y, Jing H, Zhang N, Flavel M BMC Pharmacol Toxicol. 2018; 19(1):18.
PMID: 29669598 PMC: 5907177. DOI: 10.1186/s40360-018-0208-3.
In Vitro Cell Models for Ophthalmic Drug Development Applications.
Shafaie S, Hutter V, Cook M, Brown M, Chau D Biores Open Access. 2016; 5(1):94-108.
PMID: 27158563 PMC: 4845647. DOI: 10.1089/biores.2016.0008.